Scorpion Biological Services changes name to Scorpius BioManufacturing post-expansion

The contract development and manufacturing organization (CDMO) Scorpion Biological Services will adopt the name Scorpius BioManufacturing after unveiling expanded manufacturing capabilities earlier this year. The company opened a new biomanufacturing facility in San Antonio in October. Scorpius will be headquartered in the same city.

A string of companies have also changed their name in 2022.

The smoking cessation firm Respira became Qnovia. Adagio changed its name to Invivy

CytRx became LadRx. Bone Therapeutics turned into BioSenic.

Scorpius opted to adopt a new name that “better defines our focus and full-service offering,” explained David Halverson, Scorpius president, in a news release.

In addition to its CDMO offerings, the biologics-focused company also is a contract research organization (CRO).

The company can “take our clients’ biologic innovations through the clinic to commercialization,” Halverson said.

“We have long…

Read more
  • 0

CRO Syneos Health hires new CEO

The contract research organization (CRO) Syneos Health has promoted Michelle Keefe to be its CEO and a member of its board.

Keefe was previously the president, medical affairs and commercial solutions at Morrisville, North Carolina-based Syneos.

The company’s departing CEO, Alistair Macdonald, is retiring after working at the company for two decades.

Macdonald will serve as an advisor to the company until March 2023.

Michelle Keefe

Keefe has more than three decades of experience working in the life sciences, including two decades at Pfizer.

“I am incredibly honored to take on this role and lead our talented colleagues around the globe,” Keefe wrote in a LinkedIn post. “I look forward to leveraging my decades of life sciences industry experience to help usher Syneos Health into its next chapter as a data- and insights-driven organization, addressing market opportunities with a prod…

Read more
  • 0